Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 2529 entries
View as:

A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00304525 Org: User:
Start: 04/30/06 End: 11/30/13 Due: 11/30/14

Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00464399 Org: User:
Start: 09/30/06 End: - Due: -

CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab

Phase: N/A Priority: Normal
NCT ID: NCT02634970 Org: User:
Start: 03/31/16 End: 12/31/17 Due: 12/31/18

Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064

Phase: N/A Priority: Normal
NCT ID: NCT03918980 Org: User:
Start: 08/18/16 End: 01/27/20 Due: 01/27/21

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006368 Org: User:
Start: 01/31/98 End: 11/30/03 Due: 11/30/04

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT01377597 Org: User:
Start: 06/30/11 End: 04/30/12 Due: 04/30/13

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02554786 Org: User:
Start: 12/29/15 End: 06/28/19 Due: 06/28/20

Study To Assess Long Term Safety Of Pazopanib

Phase: N/A Priority: Normal
NCT ID: NCT00387205 Org: User:
Start: 06/20/06 End: 03/08/18 Due: 03/08/19

Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00997477 Org: User:
Start: 06/30/10 End: - Due: -

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT04864392 Org: User:
Start: 05/31/21 End: 05/28/25 Due: 05/28/26

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01529307 Org: User:
Start: 06/30/12 End: 09/30/12 Due: 09/30/13

Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01566604 Org: User:
Start: 03/31/12 End: 06/30/13 Due: 06/30/14

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01915303 Org: User:
Start: 03/06/14 End: 09/04/19 Due: 09/04/20

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00063609 Org: User:
Start: 04/30/03 End: 04/30/05 Due: 04/30/06

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00098241 Org: User:
Start: 06/30/00 End: 03/31/07 Due: 03/31/08

Urine Sample Collection From FOP Patients

Phase: N/A Priority: Normal
NCT ID: NCT02066324 Org: User:
Start: 11/30/13 End: 08/31/14 Due: 08/31/15

A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05329623 Org: User:
Start: 05/03/22 End: 04/07/24 Due: 04/07/25

Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00434590 Org: User:
Start: 03/31/07 End: 05/31/08 Due: 05/31/09

A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

Phase: N/A Priority: Normal
NCT ID: NCT02300987 Org: User:
Start: 02/26/15 End: 02/21/18 Due: 02/21/19

Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT03756129 Org: User:
Start: 02/08/19 End: 03/23/20 Due: 03/23/21

Post Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01610297 Org: User:
Start: 09/30/13 End: 10/31/15 Due: 10/31/16

Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT01327664 Org: User:
Start: 03/31/11 End: - Due: -

Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201

Phase: N/A Priority: Normal
NCT ID: NCT02075008 Org: User:
Start: 03/27/14 End: 03/22/16 Due: 03/22/17

BKM120 for Patients With PI3K-activated Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01833169 Org: User:
Start: 03/29/13 End: 09/26/16 Due: 09/26/17

Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT01117987 Org: User:
Start: 04/30/10 End: 04/30/14 Due: 04/30/15